Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Williams Companies Inc (WMB) Price & Performance

Gilead Sciences, Inc.Trade
Williams Companies IncTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Williams Companies Inc — how do they compare? Gilead Sciences, Inc. trades at $135.19 (market cap $168.35B), while Williams Companies Inc trades at $71.97 (market cap $88.45B). The key difference: Gilead Sciences, Inc. is the larger of the two by market cap, and Williams Companies Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals.

GILDWMB
Market Cap
$168.35B$88.45B
Sector
HealthEnergy
52-Week High
$155.80$79.40
52-Week Low
$110.56$56.51
Enterprise Value
$191.42B$119.07B
Dividend Yield
2.42%2.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Williams Companies Inc

Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.

Read more on WMB